Free tool
Rare disease stocks
We cover 3 companies grouped under the Rare disease theme. The median market value in the group is $282.58M. Across the group, the median move over the past trading day is −1.28%. Price change over the past year runs from −81.6% to −35.3% across the middle 80 percent of the group, with a median of −75.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $139.70B | Large cap | −83.18% |
| SION | Sionna Therapeutics, Inc. | $282.58M | Small cap | −75.45% |
| MDWD | MediWound Ltd. | $163.96M | Small cap | −25.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.